Acadian Asset Management’s Lexicon Pharmaceuticals LXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-573,688
| Closed | -$263K | – | 1767 |
|
|
2025
Q1 | $263K | Buy |
+573,688
| New | +$263K | ﹤0.01% | 1203 |
|
|
2024
Q4 | – | Sell |
-58,007
| Closed | -$91K | – | 1941 |
|
|
2024
Q3 | $91K | Buy |
+58,007
| New | +$91K | ﹤0.01% | 1618 |
|
|
2021
Q2 | – | Sell |
-462,296
| Closed | -$2.71M | – | 2122 |
|
|
2021
Q1 | $2.71M | Sell |
462,296
-1,231,739
| -73% | -$7.23M | 0.01% | 649 |
|
|
2020
Q4 | $5.79M | Sell |
1,694,035
-160,275
| -9% | -$548K | 0.02% | 466 |
|
|
2020
Q3 | $2.67M | Buy |
1,854,310
+191,384
| +12% | +$275K | 0.01% | 592 |
|
|
2020
Q2 | $3.32M | Buy |
1,662,926
+586,865
| +55% | +$1.17M | 0.01% | 581 |
|
|
2020
Q1 | $2.1M | Buy |
1,076,061
+911,113
| +552% | +$1.78M | 0.01% | 589 |
|
|
2019
Q4 | $685K | Buy |
+164,948
| New | +$685K | ﹤0.01% | 989 |
|
|
2016
Q4 | – | Sell |
-4,886
| Closed | -$88K | – | 1710 |
|
|
2016
Q3 | $88K | Sell |
4,886
-55,250
| -92% | -$995K | ﹤0.01% | 1084 |
|
|
2016
Q2 | $863K | Buy |
+60,136
| New | +$863K | ﹤0.01% | 657 |
|